New York-based Norland Medical Systems, a bone densitometry vendor, appears to have rebounded from the dramatic fourth quarter and year-end losses of 1998. In 1999, the company’s revenue increased by 24%. Revenue for year-end 1999 was $17.8 million,
New York-based Norland Medical Systems, a bone densitometry vendor, appears to have rebounded from the dramatic fourth quarter and year-end losses of 1998. In 1999, the companys revenue increased by 24%. Revenue for year-end 1999 was $17.8 million, compared with $14.4 million in 1998.
Norlands net loss for the fourth quarter of 1999 was $791,000, compared to $4.3 million in the fourth quarter of 1998. CEO Reynald G. Bonmati attributes the firms recent success to cutting losses and positioning the company as a broader medical device vendor.
The company develops, manufactures, sells, and services a wide range of systems used to assess bone mineral content and density, the measurements used by physicians to diagnose and monitor bone disorders such as osteoporosis.
At the same time Norland announced positive news about its financial performance, company officials said they have started selling McCues CubaClinical, an ultrasound bone measurement system. In January, Norland received premarket approval from the Food and Drug Administration for this system (SCAN 2/2/00). The company obtained exclusive distribution rights for the product from McCue last June.
In March, Norland began marketing the McCue system to physicians across the U.S. The company is already distributing the system in Europe, Africa, the Middle East, and the Pacific Rim.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.